Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2535491rdf:typepubmed:Citationlld:pubmed
pubmed-article:2535491lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2535491lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2535491lifeskim:mentionsumls-concept:C1519839lld:lifeskim
pubmed-article:2535491lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:2535491lifeskim:mentionsumls-concept:C0017978lld:lifeskim
pubmed-article:2535491lifeskim:mentionsumls-concept:C0441800lld:lifeskim
pubmed-article:2535491pubmed:issue3lld:pubmed
pubmed-article:2535491pubmed:dateCreated1992-10-9lld:pubmed
pubmed-article:2535491pubmed:abstractTextNeutral glycolipids and gangliosides from seven human urothelial cell lines, differing in grades of transformation (TGr), were characterized by fast atom bombardment mass spectrometry, exoglycosidase treatment and an immunostaining procedure. The major neutral glycolipids identified in all cell lines studied included CMH, CDH, CTH, globoside and paragloboside, the gangliosides were GM3, GM2, sialosylparagloboside and GD1a. The following observations were made: 1. GM2 was the major ganglioside in the TGrII cell lines (non-tumorigenic, non-invasive), but a minor component in the TGrIII cell lines (tumorigenic, invasive). 2. All components showed C16:0 and C24:0 as major fatty acids, but in the TGrIII cell lines the fatty acid composition of CMH and some of the gangliosides were more complex showing unsaturated and hydroxy-fatty acids as well.lld:pubmed
pubmed-article:2535491pubmed:languageenglld:pubmed
pubmed-article:2535491pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:citationSubsetIMlld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2535491pubmed:statusMEDLINElld:pubmed
pubmed-article:2535491pubmed:issn0282-0080lld:pubmed
pubmed-article:2535491pubmed:authorpubmed-author:NilssonBBlld:pubmed
pubmed-article:2535491pubmed:authorpubmed-author:UgorskiMMlld:pubmed
pubmed-article:2535491pubmed:authorpubmed-author:RadzikowskiCClld:pubmed
pubmed-article:2535491pubmed:authorpubmed-author:DuxAAlld:pubmed
pubmed-article:2535491pubmed:authorpubmed-author:PåhlssonPPlld:pubmed
pubmed-article:2535491pubmed:issnTypePrintlld:pubmed
pubmed-article:2535491pubmed:volume6lld:pubmed
pubmed-article:2535491pubmed:ownerNLMlld:pubmed
pubmed-article:2535491pubmed:authorsCompleteYlld:pubmed
pubmed-article:2535491pubmed:pagination303-18lld:pubmed
pubmed-article:2535491pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:meshHeadingpubmed-meshheading:2535491-...lld:pubmed
pubmed-article:2535491pubmed:year1989lld:pubmed
pubmed-article:2535491pubmed:articleTitleGlycosphingolipids of human urothelial cell lines with different grades of transformation.lld:pubmed
pubmed-article:2535491pubmed:affiliationDepartment of Immunochemistry, Polish Academy of Sciences, Wroclaw.lld:pubmed
pubmed-article:2535491pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2535491pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2535491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2535491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2535491lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2535491lld:pubmed